Article

pubs.acs.org/joc

Palladium-Catalyzed Intramolecular Cyclization of Ynamides:
Synthesis of 4‑Halo-oxazolones
Hai Huang, Guangke He, Guohao Zhu, Xiaolin Zhu, Shineng Qiu, and Hongjun Zhu*
Department of Applied Chemistry, College of Sciences, Nanjing Tech University, Nanjing 211816, People’s Republic of China

*S Supporting Information

ABSTRACT: A mild and eﬃcient methodology involving Pd(PPh3)4-catalyzed intramolecular cyclization of N-alkynyl
alkyloxycarbamates with CuCl2 or CuBr2 for the synthesis of 4-halo-oxazolones was developed. This reaction exhibiting good
functional tolerance provided a new, eﬃcient, and rapid synthetic process to 4-halo-oxazolones. The resulting 4-halo-oxazolones
can serve as great potential precursors for the 3,4,5-trisubstituted oxazolones via a Pd-catalyzed cross-coupling reaction.

■ INTRODUCTION

Oxazolones are not only valuable building blocks in organic
synthesis but also a recurring functional group in a large
number of natural products and bioactive compounds.1
Therefore, great eﬀorts have been directed toward developing
synthetic approaches for the construction of this privileged
structure,2 among which the metal-catalyzed (e.g., Au, Pd, and
Cu) cyclization of the N-alkynyl
tert-butyloxycarbamates is
considered to be one of the most eﬀective strategies (Scheme 1,
a).3 For instance, Gagosz3a reported the Au-catalyzed cyclo-
isomerization, which provided the eﬃcient and rapid process
for the synthesis of 3,5-disubstituted oxazolones. Despite these

Scheme 1. Pd-catalyzed Cyclization of the N-alkynyl
alkyloxycarbamates

advances,
the eﬀective synthesis of 3,4,5-multisubstituted
oxazolones and modiﬁcation of the 4-position of oxazolones
still remain highly challenging areas.4

Meanwhile, the halopalladation of alkynes has been proven
to be an extremely eﬃcient and convenient method for the
construction of important carbo- and heterocycles in organic
synthesis.5 First, the halopalladation of alkynes generates a
versatile reactive σ-vinylpalladium intermediate. Such a σ-
vinylpalladium intermediate could be next trapped by some
nucleophilic groups leading to corresponding compounds
(Scheme 1, b). In addition, after learning of the widespread
application of the carbonyl oxygen as nucleophile in transition-
metal-catalyzed reactions,6 we conceived that during the
process of halopalladation a carbamate group could be used
as oxygen source to capture the σ-vinylpalladium intermediate.
After pursuing our recent interest in the functionalization of
ynamides,7 we herein report a novel Pd-catalyzed cyclization of
N-alkynyl alkyloxycarbamates to aﬀord the corresponding 4-
halo-oxazolones
in good yields under mild conditions.
Furthermore, this method aﬀords oxazolones with a halogen
(Cl or Br) at the 4-position, which provides an attractive and
useful route to introduce new groups for the synthesis of new
bioactive products (Scheme 1, c).8
■ RESULTS AND DISCUSSION
<para sub=“opt”>
In the initial experiments,
tert-butyl N-phenyl-N-
(phenylethynyl)carbamate (1a) was used as a model substrate
to screen the optimal reaction conditions. Compound 1a and
3.0 equiv of CuBr2 were treated with 10 mol % of Pd(OAc)2
and 2.0 equiv of t-BuOK in DMA at 60 °C. To our delight, the
</para>
Received:
January 11, 2015
Published: March 10, 2015

© 2015 American Chemical Society

3480

DOI: 10.1021/acs.joc.5b00071
J. Org. Chem. 2015, 80, 3480−3487

The Journal of Organic Chemistry
Table 1. Optimization of Reaction Conditionsa

Article

entry
1
2
3
4
5
6
7c
8d
9
10
11
12
13
14
15
16
17
18
19e

[Pd]
Pd(OAc)2
Pd(OAc)2
Pd2(dba)3
PdCl2
PdCl2(PPh3)4
Pd(PPh3)4
Pd(PPh3)4

Pd(PPh3)4
Pd(PPh3)4
Pd(PPh3)4
Pd(PPh3)4
Pd(PPh3)4
Pd(PPh3)4
Pd(PPh3)4
Pd(PPh3)4
Pd(PPh3)4
Pd(PPh3)4
Pd(PPh3)4

base

t-BuOK
Na2CO3
Na2CO3
Na2CO3
Na2CO3
Na2CO3
Na2CO3
Na2CO3
K2CO3
KHCO3
K3PO4
K2CO3
K2CO3
K2CO3
K2CO3
K2CO3
K2CO3
K2CO3
K2CO3

CuBr2 (equiv)

3.0
3.0
3.0
3.0
3.0
3.0

3.0
3.0
3.0
3.0
3.0
3.0
3.0
3.0
3.0
2.0
4.0
4.0

solvent
DMA
DMA
DMA
DMA
DMA
DMA
DMA
DMA
DMA
DMA
DMA
THF
toluene
DMSO
DCM
DMF
DMF
DMF
DMF

temp (°C)

2a/2a′ yieldb (%)

60
40
40
40
40
40
40
40
40
40
40
40
40
40
40
40
40
40
40

41/12
43/22
42/17
32/16
38/18
73/0
NR
NR
80/0
77/0
70/0
65/0
39/0
14/0
38/0
83/0
52/0
91/0
90/0

aThe reaction was carried out with 1a (0.30 mmol), Pd catalyst (10 mol %), base (0.6 mmol), and CuBr2 in solvent (2.0 mL) under N2 atmosphere
for 20 min. NR = no reaction. bYield was determined by 1H NMR on the crude reaction mixture using 1,3,5-trimethylbenzene as an internal
standard. cCompound 1a (91%) was recovered. dCompound 1a (83%) was recovered. e5.0 mol % catalyst loading.
<para sub=“opt”>
desired 4-bromo-3,5-diphenyl-3H-oxazol-2-one 2a was ob-
tained in 41% yield along with nonhalo product 3,5-diphenyl-
3H-oxazol-2-one 2a′ in 12% yield (Table 1, entry 1). Diﬀerent
Pd catalysts were applied. Interestingly, the single product 2a
was obtained in 73% yield when Pd(PPh3)4 was used as catalyst
(Table 1, entries 2−6). A blank experiment indicated that no
reaction occurred in the absence of the palladium catalyst
(Table 1, entry 7). The reaction also failed without the addition
of the copper salt (Table 1, entry 8). To further optimize the
reaction, diﬀerent bases were examined in which K2CO3 gave
the best performance (Table 1, entries 9−11). Among the
solvents screened, DMF was superior to DMA, THF, toluene,
DMSO, and DCM (Table 1, entries 12−16). The employment
of 4.0 equiv of CuBr2 gave the highest yield (91%) of 2a (Table
1, entry 18). A similar result was observed when 5.0 mol % of
Pd(PPh3)4 was utilized in the reaction (Table 1, entry 19) (for
more details, see the Supporting Information).
</para>
<para sub="scope">
Under the optimized reaction conditions, we examined the
scope and generality of various ynamides in this transformation
(Table 2). Groups such as methyl and methoxy that are
substituted in the aryl ring were tolerated and readily produced
high yields of the corresponding 4-bromo-oxazolones (Table 2,
entries 1−3). tert-Butyl N-phenyl-N-(naphthalen-2-ylethynyl)-
carbamate 1d also worked well,
leading to 4-bromo-5-
(naphthalen-2-yl)-3-phenyl-3H-oxazol-2-one 2d in 68% yield
(Table 2, entry 4). Ynamides with electron-withdrawing groups
on the meta-positions of the N-aryl ring, such as F, Cl, Br, and
CF3, generated the corresponding 4-bromo-oxazolones in 73−
90% yields (Table 2, entries 5−8). On the other hand,
ynamides with electron-donating groups, such as Me and MeO
on the meta-positions of their N-aryl rings, gave the desired
products in 91−94% yields (Table 2, entries 9 and 10).

Meanwhile, the ortho-eﬀect was not obvious for methyl and
bromo groups on the ortho-positions of the N-aryl ring in the
reactions (Table 2, entries 11 and 12). Ynamide with methyl on
the para-positions the N-aryl ring was also tolerated, leading to
the desired product in 83% yield (Table 2, entry 13). However,
ynamide with bromo on the para-positions of the N-aryl ring
gave a lower yield compared with either the meta- or ortho-
substituted product (Table 2, entry 14). Under
the
recommended reaction conditions, substrates possessing a 2-
naphthyl group on the nitrogen atom (Table 2, entry 15)
furnished the desired product in good yield. Furthermore,
ynamides with a N-benzyl or N-butyl group also successfully
produced the desired 4-bromo-oxazolones in moderate yields
(Table 2, entries 16 and 17). Alkyl-substituted ynamides could
also have moderate yield successfully under
the reaction
conditions, and the yield probably was not aﬀected by the
length of the alkyl chain (Table 2, entries 18 and 19). Finally,
the reaction of vinyl alkynyl-substituted substrate (E)-tert-butyl
(2-bromophenyl)(4-phenylbut-3-en-1-yn-1-yl)carbamate (1t)
with CuBr2 gave a good yield (Table 2, entry 20). The
structures of 2a and 2m were further conﬁrmed via single-
crystal X-ray diﬀraction (for more details, see the Supporting
Information).
</para>
<para sub="scope">
We also tested the Pd-catalyzed cyclizations of N-alkynyl tert-
butyloxycarbamates 1 in the presence of CuCl2 (Table 2,
entries 21−26). These reactions proceeded well
to aﬀord
chloro-containing oxazolones 3 in moderate to good yields. For
example, a 74% yield of product 3a was obtained when 1a was
employed in a reaction with CuCl2. Moreover, under the
optimized reaction conditions, various
substrates bearing
groups on the ortho-, meta-, and para-positions of the N-aryl
ring were converted (moderate to high yields) into the
</para>
3481

DOI: 10.1021/acs.joc.5b00071
J. Org. Chem. 2015, 80, 3480−3487

The Journal of Organic Chemistry
Table 2. Pd-Catalyzed Formation of 4-Bromo-oxazolonesa

Table 3. Cyclizations of Ynamides Containing Various
Leaving Groupsa

Article

R
Ph (1a)
p-MePh (1b)
p-MeOPh (1c)
2-naphthyl

(1d)

Ph

entry
1
2
3
4b

5
6
7
8
9
10
11
12
13
14
15b

R1

Ph

m-FPh (1e)
m-ClPh (1f)
m-BrPh (1g)
m-CF3Ph (1h)
m-MePh (1i)
m-MeOPh (1j)
o-MePh (1k)
o-BrPh (1l)
p-MePh (1m)
p-BrPh (1n)
2-naphthyl

(1o)

X
Br

Br

product

2a
2b
2c
2d

2e
2f
2g
2h
2i
2j
2k
2l
2m
2n
2o

isolated yield

(%)
84
93
85
68

73
87
90
83
94
91
94
98
83
64
74

entry

R2

1
2
3
4

Et (1u)
i-Pr (1v)
t-Bu (1a)
Bn (1w)

time
20 h
20 h
20 min
20 min

yield of 2ab (%)

recovery of 1b (%)

30
34
90
65

33
39
0
0

aReaction conditions: 1 (0.3 mmol), Pd(PPh3)4 (5.0 mol %), CuBr2
(4.0 equiv), and K2CO3 (0.6 mmol) in DMF (2.0 mL) at 40 °C. bIt
was determined by 1H NMR on the crude reaction mixture using
1,3,5-trimethylbenzene as an internal standard.
Scheme 2. Scale-up Experiment and Suzuki−Miyaura
Coupling

Br

Br
Cl

Bn (1p)
n-C4H9 (1q)
Ph

n-C4H9 (1r)
n-C8H17 (1s)
(E)-styryl (1t)
Ph

16
17
18
19
20
21c
22c
23c
24c
25c
26c
aReaction conditions: 1 (0.3 mmol), Pd(PPh3)4 (5.0 mol %), CuX2
(4.0 equiv), and K2CO3 (0.6 mmol) in DMF (2.0 mL) at 40 °C for 20
min. bReaction time was 30 min. cReaction time was 40 min.

o-BrPh
Ph (1a)
m-BrPh (1g)
m-MeOPh (1j)
o-BrPh (1l)
p-BrPh (1n)
Bn (1p)

2p
2q
2r
2s
2t
3a
3g
3j
3l
3n
3p

51
53
54
49
71
74
84
88
87
65
81
<para sub="scope">
corresponding 4-chloro-oxazolones. Ynamides in general give a
relatively poor or similar yield in the presence of CuCl2
compared with the CuBr2 conditions (Table 2, entries 21−
25);
tert-butyl N-benzyl-N-(phenylethynyl)-
carbamate (1p) took part in the reaction readily and was
transformed to the corresponding product in 81% yield.

interestingly,

i-Pr,
</para>
<para sub="scope">
In Table 3, we then studied the eﬀect of varying leaving
groups (e.g., Et,
t-Bu, Bn) on the ester moiety. For
ynamides containing leaving groups, such as Et and i-Pr,
cyclization took place in poor yields. As reported,9 N-
carbobenzyloxy (N-Cbz)-protected amines were great potential
structures for the synthesis of cyclic carbamates, and N-Cbz-
protected ynamide (1w) exhibited good reactivity to aﬀord 2a
in satisfying yield.
</para>
<para sub="scope">
To demonstrate the synthetic potential of this strategy, 1a
(1.41 g, 5 mmol) was allowed to react under the optimized
conditions. This reaction could be scaled up to 5 mmol in a
high yield, and the Pd catalyst loading could be reduced to 3%
mol with comparable eﬃciency (Scheme 2). We then
attempted to introduce more groups into the oxazolone
scaﬀold via Pd-catalyzed cross-coupling reactions. Thus, the
Suzuki−Miyaura coupling reaction was investigated (Scheme 2,
(i)). Product 2 easily underwent a Suzuki-coupling reaction by
</para>
<para sub="scope">
To understand the mechanism of
</para>
<para sub="scope">
treatment with arylboronic acids under toluene/EtOH/H2O
conditions using Pd(PPh3)4 as the Pd catalyst (Scheme 2, (ii)).
</para>
<para sub="scope">
the reaction, control
experiments were conducted (Scheme 3). Compound 1a could
not produce 4-chloro-3,5-diphenyl-3H-oxazol-2-one 3a in the
absence of CuCl2 using 1.0 equiv of PdCl2(PPh3)2 as chlorine
source, which revealed that C−X formation does not originate
from the cleavage of the C−Pd bond.10 In contrast, the desired
product was obtained in 41% yield in the presence of CuCl2. It
is noteworthy that 1a also failed to produce the corresponding
oxazolone 3a using the Pd(PPh3)4/CuCl system instead of the
Pd(PPh3)4/CuCl2 system. These results revealed the important
role of CuX2 in this cyclization system. Furthermore, the non-
halo product 3,5-diphenyl-3H-oxazol-2-one 2a′ could not
produce 3a under
the recommended reaction conditions,
which suggested that the formation of C−X bond might be
followed by the intramolecular cyclization.
</para>
<para sub="scope">
According to the experimental results and the reported
literature, a proposed mechanism for this Pd(PPh3)4-catalyzed
intramolecular cyclization of N-alkynyl alkyloxycarbamates is
shown in Scheme 4. Pd(0) was ﬁrst converted to Pd(II) species
in this reaction system.11 The activation of the triple bond in N-
alkynyl alkyloxycarbamates 1 with Pd(II) produces
the
intermediate A.12 Nucleophilic attack of the bromo or chloro
anion generates σ-vinylpalladium intermediate B,5e,11a,13 which
transforms into the oxopalladium complex C coordinating with
base.14 The resulting oxopalladium intermediate C has been
suggested to undergo the reductive elimination to form the
corresponding 4-halo-oxazolones and the Pd(0) species.15
</para>
3482

DOI: 10.1021/acs.joc.5b00071
J. Org. Chem. 2015, 80, 3480−3487

The Journal of Organic Chemistry

Scheme 3. Experiment for Mechanistic Study

Article

Scheme 4. Proposed Mechanism for this Cyclization

■ CONCLUSIONS

In summary, we have developed a novel and eﬃcient protocol
for the synthesis of 4-halo-oxazolones by the halopalladation
and carbon−oxygen-forming process.
In the presence of
Pd(PPh3)4 and CuX2 (X = Cl or Br), a variety of N-alkynyl
alkyloxycarbamates underwent the reaction to aﬀord 4-halo-
oxazolones in moderate to excellent yields. Moreover, a halogen
at the 4-position of these products provides an attractive and
useful route to introduce new groups for the synthesis of new
bioactive products. Further
studies on transition-metal-
catalyzed C−C, C−N, and C−O bond formation of ynamides
are being conducted in our laboratory and will be reported in
due course.

■ EXPERIMENTAL SECTION
<para sub=“exp”>
General Methods. All reactions were performed in reaction tubes
under nitrogen atmosphere. 1H NMR and 13C NMR were recorded at,
respectively, 400 and 100 MHz using CDCl3 as solvent. The following
abbreviations are used to describe peak patterns where appropriate: b
=broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet.
Coupling constants are reported in hertz (Hz). Chemical shifts are
reported in ppm relative to the internal standard tetramethylsilane (δ
= 0 ppm) for 1H NMR and deuteriochloroform (δ = 77.00 ppm) for
13C NMR. High-resolution mass spectra (HRMS) were recorded on
an ESI-TOF (time-of-ﬂight) mass spectrometer. Melting points were
measured with a micro melting point apparatus.

Ynamide Synthesis: Typical Procedure I. Compounds were
synthesized according to a literature procedure.3a To a mixture of
·5H2O (0.8 mmol),
carbamates (8.0 mmol), K3PO4 (16 mmol), CuSO4
and 1,10-phenanthroline (1.6 mmol) in a reaction vial was added a
solution of bromoalkyne16 (8.8 mmol) in toluene (15 mL). The
reaction mixture was capped and heated in an oil bath at 85 °C for 18
h while being monitored by TLC. Upon completion, the reaction
mixture was cooled to room temperature, diluted with EtOAc, and
ﬁltered through Celite, and the ﬁltrate was concentrated in vacuum.
The crude products were puriﬁed by silica gel ﬂash chromatography
on a silica gel column with petroleum ether (PE) and ethyl acetate
(EA) as eluent to aﬀord directing products.
tert-Butyl N-(phenylethynyl)-N-(p-tolyl)carbamate (1b): yield 68%
(1.66 g); white solid; mp 71−72 °C (n-hexane/ethyl acetate); Rf 0.20
(vPE/vEA = 50:1); 1H NMR δ 7.55−7.50 (m, 2 H), 7.42−7.35 (m, 2
H), 7.30 (d, J = 8.4 Hz, 2 H), 7.27−7.22 (m, 1 H), 7.10 (d, J = 8.0 Hz,
2 H), 2.33 (s, 3 H), 1.56 (s, 9H); 13C NMR δ 153.0, 139.8, 137.4,
130.9, 129.0, 128.7, 126.5, 124.6, 120.2, 83.4, 82.9, 70.0, 28.0, 21.4; IR
ν (KBr, cm−1) 2991, 1732, 1643, 1617, 1491, 1397, 1364, 1287, 1254,
1150, 1004, 820, 769; MS (ESI) m/z 330.0(100) [M + Na]+. Anal.
Calcd for C20H21NO2: C, 78.15; H, 6.89; N, 4.56. Found: C, 78.06; H,
7.34; N, 4.61.

tert-Butyl N-((4-methoxyphenyl)ethynyl)-N-(phenyl)carbamate
(1c): yield 67% (1.73 g); yellow oil; Rf 0.20 (vPE/vEA = 50:1); 1H
NMR δ 7.44 (dd, J1 = 1.2 Hz, J2 = 8.8 Hz, 2 H), 7.32−7.24 (m, 4 H),
7.15 (t, J = 7.6 Hz, 1 H), 6.74 (d, J = 8.8 Hz, 2 H), 3.69 (s, 3 H), 1.47
(s, 9H); 13C NMR δ 158.0, 152.0, 138.8, 131.6, 127.7, 125.4, 123.6,
114.2, 112.8, 82.3, 81.1, 68.6, 54.2, 26.9; IR ν (KBr, cm−1) 2977, 1731,
1602, 1511, 1364, 1288, 1249, 1155, 1031, 831, 762; MS (ESI) m/z
346.1(100) [M + Na]+; HRMS (ESI-TOF) m/z calcd for C20H21NO3
[M + Na]+ 346.1403, found 346.1409.

tert-Butyl N-(naphthalen-2-ylethynyl)-N-(phenyl)carbamate (1d):
yield 45% (1.21 g); yellow oil; Rf 0.20 (vPE/vEA = 40:1); 1H NMR δ
7.82 (s, 1 H), 7.72−7.65 (m, 3 H), 7.51−7.46 (m, 2 H), 7.41−7.31
(m, 5 H), 7.23−7.17 (m, 1 H), 1.51 (s, 9H); 13C NMR δ 151.9, 138.6,
132.1, 131.3, 129.1, 127.8, 127.1, 126.8, 126.7, 126.5, 125.7, 125.4,
125.2, 123.7, 119.7, 82.6, 69.5, 27.0; IR ν (KBr, cm−1) 1770, 1623,
1497, 1378, 1228, 1173, 1056, 1008, 977, 750, 694; MS (ESI) m/z
366.2 (100) [M + Na]+; HRMS (ESI-TOF) m/z calcd for C23H21NO2
[M + Na]+ 366.1470, found 366.1482.
tert-Butyl N-(3-methoxyphenyl)-N-(phenylethynyl)carbamate
(1j): yield 74% (1.88 g); white solid; mp 57−58 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 50:1); 1H NMR δ 7.42−7.37 (m, 2 H),
7.32−7.29 (m, 4 H), 7.16−7.09 (m, 2 H), 6.81 (dd, J1 = 2.0 Hz, J2 =
8.0 Hz, 1 H), 3.82 (s, 3 H), 1.57 (s, 9H); 13C NMR δ 159.9, 152.8,
140.7, 130.8, 129.4, 128.2, 127.4, 123.4, 117.0, 112.3, 110.6, 83.5, 70.3,
55.4, 28.0; IR ν (KBr, cm−1) 2977, 2934, 1731, 1602, 1511, 1364,
1288. 1249, 1155, 1031, 831, 762; MS (ESI) m/z 346.1 (100) [M +
</para>
3483

DOI: 10.1021/acs.joc.5b00071
J. Org. Chem. 2015, 80, 3480−3487

The Journal of Organic Chemistry
<para sub=“exp”>
Na]+. Anal. Calcd for C20H21NO3: C, 74.28; H, 6.55; N, 4.33. Found:
C, 74.36; H, 6.80; N, 4.17.
Ethyl N-phenyl-N-(phenyl-ethynyl)carbamate (1u):17 yield 76%
(1.62 g); yellow oil; Rf 0.20 (vPE/vEA = 20:1); 1H NMR δ 7.57−7.52
(m, 2 H), 7.45−7.38 (m, 4 H), 7.33−7.25 (m, 4 H), 4.35 (q, J = 7.2
Hz, 2 H), 1.38 (t, J = 7.2 Hz, 3 H); 13C NMR δ 154.3, 139.5, 131.2,
128.9, 128.2, 127.7, 126.9, 124.6, 123.0, 83.0, 70.1, 63.7, 14.3.
Isopropyl N-phenyl-N-(phenylethynyl)carbamate (1v): yield 59%
(1.30 g); yellow oil; Rf 0.20 (vPE/vEA = 20:1); 1H NMR δ 7.57−7.52
(m, 2 H), 7.43−7.37 (m, 4 H), 7.33−7.26 (m, 4 H), 5.08 (m, 1 H),
1.37 (d, J = 6.4 Hz, 3 H); 13C NMR δ 153.8, 139.6, 131.1, 128.9,
128.2, 127.5, 126.7, 124.6, 123.2, 83.2, 71.9, 70.1, 21.9; HRMS (ESI-
TOF) m/z calcd for C18H17NO2 [M + Na]+ 302.1157,
found
302.1163.
Benzyl N-phenyl-N-(phenylethynyl)carbamate (1w): yield 29%
(0.76 g); yellow oil; Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.57−7.53
(m, 2 H), 7.46−7.33 (m, 9 H), 7.32−7.26 (m, 4 H), 5.33 (s, 2 H); 13C
NMR δ 154.1, 139.4, 135.4, 131.2, 129.0, 128.6, 128.3, 128.2, 127.9,
127.7, 127.0, 124.6, 122.9, 82.8, 70.4, 68.9; HRMS (ESI-TOF) m/z
calcd for C22H17NO2 [M + Na]+ 350.1157, found 350.1169.

General Procedure for Pd-Catalyzed Synthesis of 4-Halo-
oxazolones in the Presence of CuX2: Typical Procedure II.
Ynamides 1 (0.3 mmol), Pd(PPh3)4 (0.015 mmol), CuX2 (1.2 mmol),
K2CO3 (0.6 mmol), and DMF (2.0 mL) were placed into a 10 mL
Schlenk tube, and then the temperature was increased to 40 °C. The
solution was stirred under an N2 atmosphere for 20 min and
monitored by TLC. After being cooled to room temperature, the
reaction mixture was quenched with ethyl acetate (15 mL) and washed
with water (30 mL). The aqueous phase was extracted twice with
EtOAc (3 × 10 mL), and the combined organic layer was dried over
anhydrous Na2SO4. After evaporation of the solvents under vacuum,
the crude products were puriﬁed by ﬂash chromatography on a silica
gel column with petroleum ether (PE) and ethyl acetate (EA) as the
eluent to aﬀord the desired product.
4-Bromo-3,5-diphenyl-3H-oxazol-2-one (2a): yield 84% (80.3
mg); white solid; mp 160−161 °C (n-hexane/ethyl acetate); Rf 0.20
(vPE/vEA = 15:1); 1H NMR δ 7.88−7.83 (m, 2 H), 7.56−7.35 (m, 8
H); 13C NMR δ 152.1, 136.7, 132.8, 129.4, 129.2, 128.8, 128.7, 127.7,
126.5, 124.9, 97.7; IR ν (KBr, cm−1) 3062, 1745, 1498, 1379, 1223,
1058, 966, 756, 690; MS (ESI) m/z 338.0 (100) [M + Na]+. Anal.
Calcd for C15H10BrNO2: C, 56.99; H, 3.19; N, 4.43. Found: C, 57.00;
H, 3.32; N, 4.15.
3,5-Diphenyl-3H-oxazol-2-one (2a′):1 1H NMR δ 7.62 (d, J = 7.6
Hz, 2 H), 7.56 (d, J = 7.2 Hz, 2 H), 7.47 (t, J = 7.6 Hz, 2 H), 7.42 (t, J
= 7.2 Hz, 2 H), 7.36−7.28 (m, 2 H), 7.17 (s, 1 H); 13C NMR δ 152.6,
139.9, 135.5, 129.5, 128.9, 128.6, 127.0, 126.6, 123.2, 121.0, 108.4;
4-Bromo-3-phenyl-5-(p-tolyl)-3H-oxazol-2-one (2b): yield 93%
(91.8 mg); white solid; mp 170−171 °C (n-hexane/ethyl acetate);
Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.74 (d, J = 8.4 Hz, 2 H), 7.56−
7.38 (m, 5 H), 7.26 (d, J = 8.4 Hz, 2 H), 2.39 (s, 3 H); 13C NMR δ
152.2, 139.0, 137.0, 132.9, 129.39, 129.37, 129.1, 127.7, 124.9, 123.7,
96.9, 21.4; IR ν (KBr, cm−1) 3056, 1763, 1621, 1496, 1376, 1229,
1060, 1008, 966, 813, 696; MS (ESI) m/z 352.0 (100) [M + Na]+.
Anal. Calcd for C16H12BrNO2: C, 58.20; H, 3.66; N, 4.24. Found: C,
58.16; H, 3.76; N, 4.03.
4-Bromo-5-(4-methoxyphenyl)-3-phenyl-3H-oxazol-2-one (2c):
yield 85% (88.6 mg); white solid; mp 159−160 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.79 (d, J = 9.2 Hz, 2
H), 7.55−7.44 (m, 3 H), 7.43−7.38 (m, 2 H), 6.98 (d, J = 9.2 Hz, 2
H), 3.86 (s, 3 H); 13C NMR δ 160.0, 152.2, 136.9, 133.0, 129.4, 129.1,
127.7, 126.6, 119.1, 114.2, 95.9, 55.4; IR ν (KBr, cm−1) 3066, 1774,
1598, 1504, 1369, 1254, 1220, 1177, 1063, 1018, 964, 862, 701; MS
(ESI) m/z 368.0 (100) [M + Na]+. Anal. Calcd for C16H12BrNO3: C,
55.51; H, 3.49; N, 4.05. Found: C, 55.67; H, 3.60; N, 3.80.
4-Bromo-5-(naphthalen-2-yl)-3-phenyl-3H-oxazol-2-one (2d):
yield 68% (74.0 mg); white solid; mp 178−180 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 10:1); 1H NMR δ 8.32 (s, 1 H), 7.99 (dd,
J1= 1.6 Hz, J2 = 8.4 Hz, 1 H), 7.92−7.82 (m, 3 H), 7.57−7.42 (m, 7
H); 13C NMR δ 152.2, 136.9, 133.0, 132.9, 132.8, 129.4, 129.3, 128.5,
128.4, 127.8, 127.7, 126.9, 126.8, 124.6, 123.8, 122.0, 98.1; IR ν (KBr,
</para>
Article
<para sub=“exp”>
cm−1) 1737, 1690, 1617, 1530, 1496, 1395, 1302, 1251, 1152, 818,
747; MS (ESI) m/z 388.1 (100) [M + Na]+. Anal. Calcd for
C19H12BrNO2: C, 62.32; H, 3.30; N, 3.82. Found: C, 62.41; H, 3.47;
N, 3.57.
4-Bromo-3-(3-ﬂuorophenyl)-5-phenyl-3H-oxazol-2-one (2e):
yield 73% (73.6 mg); white solid; mp 169−170 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.87−7.83 (m, 2 H),
7.55−7.35 (m, 4 H), 7.26−7.16 (m, 3 H); 13C NMR δ 162.6 (d),
151.8, 137.1, 134.0 (d), 130.6 (d), 129.0, 128.8, 126.3, 125.0, 123.5
(d), 116.4 (d), 115.3 (d), 97.1; IR ν (KBr, cm−1) 1749, 1638, 1615,
1389, 1237, 1063, 1021, 983, 760, 682; MS (ESI) m/z 356.0 (100) [M
+ Na]+. Anal. Calcd for C15H9BrFNO2: C, 53.92; H, 2.71; N, 4.19.
Found: C, 53.92; H, 2.67; N, 4.08.
4-Bromo-3-(3-chlorophenyl)-5-phenyl-3H-oxazol-2-one (2f):
yield 87% (91.8 mg); white solid; mp 156−157 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.85 (d, J = 7.6 Hz, 2
H), 7.50−7.43 (m, 5 H), 7.42−7.30 (m, 2 H); 13C NMR δ 151.8,
137.1, 135.0, 133.8, 130.3, 129.5, 129.0, 128.8, 128.0, 126.3, 125.9,
125.0, 97.1; IR ν (KBr, cm−1) 3077, 1747, 1640, 1591, 1483, 1380,
1226, 1060, 976, 757,691; MS (ESI) m/z 372.0 (100) [M + Na]+.
Anal. Calcd for C15H9BrClNO2: C, 51.39; H, 2.59; N, 4.00. Found: C,
51.43; H, 2.53; N, 3.67.
4-Bromo-3-(3-bromophenyl)-5-phenyl-3H-oxazol-2-one (2g):
yield 90% (109.7 mg); white solid; mp 142−143 °C (n-hexane/
ethyl acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.85 (d, J = 7.2 Hz,
2 H), 7.63−7.59 (m, 2 H), 7.50−7.35 (m, 5 H); 13C NMR δ 151.8,
137.1, 133.9, 132.4, 130.8, 130.6, 129.0, 128.8, 126.4, 126.2, 125.0,
122.7, 97.1; IR ν (KBr, cm−1) 3059, 1750, 1658, 1595, 1501, 1397,
1214, 1133, 1052, 1023, 980, 733, 689; MS (ESI) m/z 416.0 (48) [M
+ Na]+. Anal. Calcd for C15H9Br2NO2: C, 45.61; H, 2.30; N, 3.55.
Found: C, 45.75; H, 2.33; N, 3.38.
4-Bromo-5-phenyl-3-(3-(triﬂuoromethyl)phenyl)-3H-oxazol-2-
one (2h): yield 83% (95.7 mg); white solid; mp 136−137 °C (n-
hexane/ethyl acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.88−7.83
(m, 2 H), 7.76−7.62 (m, 4 H), 7.50−7.38 (m, 3 H); 13C NMR δ
151.8, 137.4, 133.4, 132.1 (q), 131.0, 130.1, 129.2, 128.8, 126.2, 125.9
(q), 125.1, 124.8 (q), 122.0, 96.8; IR ν (KBr, cm−1) 3065, 1756, 1641,
1453, 1392, 1324, 1179,1121,749, 687; MS (ESI) m/z 406.0 (100) [M
+ Na]+. Anal. Calcd for C16H9BrF3NO2: C, 50.03; H, 2.36; N, 3.65.
Found: C, 50.22; H, 2.52; N, 3.25.
4-Bromo-5-phenyl-3-(m-tolyl)-3H-oxazol-2-one (2i): yield 94%
(93.8 mg); white solid; mp 123−124 °C (n-hexane/ethyl acetate);
Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.86 (d, J = 7.6 Hz, 2 H), 7.48−
7.34 (m, 4 H), 7.28 (d, J = 7.6 Hz, 1 H), 7.24−7.17 (m, 2 H), 2.43 (s,
3 H); 13C NMR δ 152.2, 139.6, 136.6, 132.7, 130.1, 129.2, 128.8,
128.7, 128.3, 126.6, 124.9, 124.8, 97.9, 21.3; IR ν (KBr, cm−1) 3057,
1747, 1637, 1611, 1490, 1446, 1379, 1228, 1059, 1026, 976, 738, 692;
MS (ESI) m/z 352.1 (100) [M + Na]+. Anal. Calcd for C16H12BrNO2:
C, 58.20; H, 3.66; N, 4.24. Found: C, 58.34; H, 3.35; N, 4.05.
4-Bromo-3-(3-methoxyphenyl)-5-phenyl-3H-oxazol-2-one (2j):
yield 91% (93.2 mg); white solid; mp 131−132 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.86 (d, J = 7.2 Hz, 2
H), 7.47−7.35 (m, 4 H), 7.04−6.97 (m, 2 H), 6.94 (t, J = 2.0 Hz, 1
H), 3.85 (s, 3 H); 13C NMR δ 160.3, 152.1, 136.7, 133.8, 130.1, 128.8,
128.7, 126.5, 124.9, 119.9, 115.2, 113.5, 97.7, 55.5; IR ν (KBr, cm−1)
3074, 1746, 1598, 1493, 1380, 1255, 1226, 1036, 982, 783, 681; MS
(ESI) m/z 368.0 (100) [M + Na]+. Anal. Calcd for C16H12BrNO3: C,
55.51; H, 3.49; N, 4.05. Found: C, 55.55; H, 3.52; N, 3.88.
4-Bromo-5-phenyl-3-(o-tolyl)-3H-oxazol-2-one (2k): yield 94%
(95.0 mg); white solid; mp 97−98 °C (n-hexane/ethyl acetate); Rf
0.20 (vPE/vEA = 15:1); 1H NMR δ 7.87 (d, J = 7.6 Hz, 2 H), 7.48−7.31
(m, 6 H), 7.26 (d, J = 6.4 Hz, 1 H), 2.29 (s, 3 H); 13C NMR δ 151.7,
137.3, 136.6, 131.7, 131.3, 130.2, 129.2, 128.7, 127.1, 126.6, 124.7,
98.4, 17.6; IR ν (KBr, cm−1) 3071, 1771, 1624, 1491, 1367, 1233,
1057, 1000, 960, 764, 679; MS (ESI) m/z 368.0 (100) [M + Na]+.
Anal. Calcd for C16H12BrNO2: C, 58.20; H, 3.66; N, 4.24. Found: C,
58.01; H, 3.54; N, 4.19.
4-Bromo-3-(2-bromophenyl)-5-phenyl-3H-oxazol-2-one (2l):
yield 98% (116.8 mg); white solid; mp 129−130 °C (n-hexane/
ethyl acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.89−7.86 (m, 2
</para>
3484

DOI: 10.1021/acs.joc.5b00071
J. Org. Chem. 2015, 80, 3480−3487

The Journal of Organic Chemistry
<para sub=“exp”>
H), 7.78 (dd, J1 = 1.2 Hz, J2 = 8.0 Hz, 1 H), 7.53−7.36 (m, 6 H); 13C
NMR δ 151.4, 136.8, 133.8, 132.2, 131.7, 131.3, 128.8, 128.7, 128.6,
126.5, 124.8, 124.3, 98.0; IR ν (KBr, cm−1) 3088, 1750, 1711, 1623,
1478, 1379, 1230, 1189, 1051, 966, 762,677; MS (ESI) m/z 416.0 (48)
[M + Na]+. Anal. Calcd for C15H9Br2NO2: C, 45.61; H, 2.30; N, 3.55.
Found: C, 45.76; H, 2.22; N, 3.28.
4-Bromo-5-phenyl-3-(p-tolyl)-3H-oxazol-2-one (2m): yield 83%
(82.1 mg); white solid; mp 145−146 °C (n-hexane/ethyl acetate); Rf
0.20 (vPE/vEA = 15:1); 1H NMR δ 7.85 (d, J = 7.2 Hz, 2 H), 7.44 (t, J =
7.2 Hz, 2 H), 7.40−7.25 (m, 5 H), 2.42 (s, 3 H); 13C NMR δ 152.3,
139.5, 136.5, 130.2, 130.1, 128.7, 128.6, 127.6, 126.6, 124.9, 98.1, 21.2;
IR ν (KBr, cm−1) 3039, 1768, 1619, 1512, 1447, 1371, 1228, 1167,
1058, 1000, 963, 748, 683; MS (ESI) m/z 352.1 (100) [M + Na]+.
Anal. Calcd for C16H12BrNO2: C, 58.20; H, 3.66; N, 4.24. Found: C,
58.32; H, 3.32; N, 3.91.
4-Bromo-3-(4-bromophenyl)-5-phenyl-3H-oxazol-2-one (2n):
yield 64% (80.3 mg); white solid; mp 200−201 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.85 (d, J = 7.2 Hz, 2
H), 7.66 (d, J = 8.8 Hz, 2 H), 7.46 (t, J = 6.4 Hz, 2H), 7.42−7.36 (m, 1
H), 7.31 (d, J = 6.4 Hz, 2 H); 13C NMR δ 151.8, 137.1, 132.7, 131.8,
129.2, 129.0, 128.8, 126.3, 125.0, 123.3, 97.2; IR ν (KBr, cm−1) 3089,
1768, 1485, 1374, 1221, 1061, 1003, 963, 764, 681; MS (ESI) m/z
416.0 (52) [M + Na]+. Anal. Calcd for C15H9Br2NO2: C, 45.61; H,
2.30; N, 3.55. Found: C, 45.97; H, 2.33; N, 3.39.
4-Bromo-3-(naphthalen-2-yl)-5-phenyl-3H-oxazol-2-one (2o):
yield 74% (79.6 mg); white solid; mp 170−171 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 10:1); 1H NMR δ 8.03 (d, J = 8.0 Hz, 1
H), 7.99−7.95 (m, 1 H), 7.94−7.90 (m, 2 H), 7.75−7.70 (m, 1 H),
7.64−7.54 (m, 4 H), 7.48 (t, J = 7.2 Hz, 2 H), 7.43−7.37 (m, 1 H);
13C NMR δ 152.3, 136.8, 134.4, 130.7, 130.5, 129.1, 128.8, 128.7,
128.6, 127.8, 127.7, 127.0, 126.6, 125.3, 124.8, 122.1, 99.2; IR ν (KBr,
cm−1) 3062, 1769, 1625, 1404, 1236, 1052, 988, 772, 677; MS (ESI)
m/z 388.1 (100) [M + Na]+. Anal. Calcd for C19H12BrNO2: C, 62.32;
H, 3.30; N, 3.82. Found: C, 62.71; H, 3.35; N, 3.99.
3-Benzyl-4-bromo-5-phenyl-3H-oxazol-2-one (2p): yield 51%
(51.5 mg); white solid; mp 122−123 °C (n-hexane/ethyl acetate);
Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.77 (d, J = 7.2 Hz, 2 H), 7.45−
7.29 (m, 8 H), 4.91 (s, 2 H); 13C NMR δ 153.3, 136.0, 135.3, 128.9,
128.64, 128.59, 128.2, 127.8, 126.6, 124.7, 97.3, 46.7; IR ν (KBr, cm−1)
3058, 1758, 1618, 1362, 1184, 1055, 997, 767, 711; MS (ESI) m/z
352.9 (100) [M + Na]+. Anal. Calcd for C16H12BrNO2: C, 58.20; H,
3.66; N, 4.24. Found: C, 58.32; H, 3.48; N, 4.17.

4-Bromo-3-butyl-5-phenyl-3H-oxazol-2-one (2q): yield 53% (46.7
mg); colorless oil; Rf 0.20 (vPE/vEA = 40:1); 1H NMR δ 7.78 (d, J = 7.6
Hz, 2 H), 7.42 (t, J = 7.2 Hz, 2 H), 7.33 (t, J = 7.6 Hz, 1 H), 3.71 (t, J
= 7.3 Hz, 2 H), 1.79−1.68 (m, 2 H), 1.49−1.38 (m, 2 H), 0.98 (t, J =
7.2 Hz, 3 H); 13C NMR δ 153.0, 135.7, 128.6, 128.4, 126.7, 124.6,
97.4, 43.1, 30.8, 19.7, 13.6; IR ν (KBr, cm−1) 2958, 1767, 1628, 1446,
1358, 1196, 1101, 1051,1027, 984, 749, 695; MS (ESI) m/z 318.1
(100) [M + Na]+; HRMS (ESI-TOF) m/z calcd for C13H14BrNO2 [M
+ Na]+ 318.0106, found 318.0113.
4-Bromo-5-butyl-3-phenyl-3H-oxazol-2-one (2r): yield 54% (47.2
mg); white solid; mp 83−85 °C (n-hexane/ethyl acetate); Rf 0.20
(vPE/vEA = 30:1); 1H NMR δ 7.51−7.45 (m, 2 H), 7.44−7.39 (m, 1
H), 7.38−7.33 (m, 2 H), 2.51 (t, J = 7.2 Hz, 2 H), 1.69−1.60 (m, 2
H), 1.46−1.35 (m, 2 H), 0.96 (t, J = 7.2 Hz, 3 H); 13C NMR δ 153.0,
139.6, 133.2, 129.2, 128.7, 127.2, 97.7, 28.8, 24.7, 21.9, 13.6; IR ν
(KBr, cm−1) 2958, 1747, 1665, 1616, 1378, 1222, 1156, 984, 761, 696;
MS (ESI) m/z 318.1 (100) [M + Na]+. Anal. Calcd for C13H14BrNO2:
C, 52.72; H, 4.76; N, 4.73. Found: C, 52.37; H, 4.89; N, 4.57.
4-Bromo-5-octyl-3-phenyl-3H-oxazol-2-one (2s): yield 49% (52.5
mg); white solid; mp 59−60 °C (n-hexane/ethyl acetate); Rf 0.20
(vPE/vEA = 40:1); 1H NMR δ 7.51−7.45 (m, 2 H), 7.44−7.39 (m, 1
H), 7.38−7.33 (m, 2 H), 2.51 (t, J = 7.2 Hz, 2 H), 1.70−1.61 (m, 2
H), 1.41−1.26 (m, 10 H), 0.89 (t, J = 6.8 Hz, 3 H); 13C NMR δ 153.0,
139.7, 133.2, 129.2, 128.7, 127.2, 97.6, 31.8, 29.7, 29.1, 28.8, 26.8, 25.0,
22.6, 14.1; IR ν (KBr, cm−1) 2958, 1747, 1665, 1616, 1378, 1222,
1156, 984, 761, 696; MS (ESI) m/z 374.0 (100) [M + Na]+. Anal.
Calcd for C17H22BrNO2: C, 57.96; H, 6.29; N, 3.98. Found: C, 57.88;
H, 6.43; N, 3.67.
</para>
Article
<para sub=“exp”>
(E)-4-Bromo-3-(2-bromophenyl)-5-styryl-3H-oxazol-2-one (2t):
yield 71% (89.8 mg); white solid; mp 149−150 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.76 (d, J = 8.0 Hz, 1
H), 7.52−7.46 (m, 3 H), 7.43−7.35 (m, 4 H), 7.30 (t, J = 7.2 Hz, 1
H), 7.07 (d, J = 16.0 Hz, 1 H), 6.68 (d, J = 16.4 Hz, 1 H); 13C NMR δ
151.2, 137.7, 135.9, 133.8, 132.1, 131.7, 131.0, 130.2, 128.8, 128.6,
128.5, 126.7, 124.0, 110.4, 100.2; IR ν (KBr, cm−1) 2924, 1761, 1481,
1446, 1379, 1162, 1234, 1055, 991, 955, 751; MS (ESI) m/z 441.9
(56) [M + Na]+. Anal. Calcd for C17H11Br2NO2: C, 48.49; H, 2.63; N,
3.33. Found: C, 48.71; H, 2.48; N, 3.57.
4-Chloro-3,5-diphenyl-3H-oxazol-2-one (3a): yield 74% (59.4
mg); white solid; mp 139−140 °C (n-hexane/ethyl acetate); Rf 0.20
(vPE/vEA = 15:1); 1H NMR δ 7.80 (d, J = 7.2 Hz, 2 H), 7.53 (t, J = 7.2
Hz, 2 H), 7.50−7.41 (m, 5 H), 7.37 (t, J = 7.6 Hz, 1 H); 13C NMR δ
151.5, 134.4, 131.9, 129.5, 129.1, 128.8, 128.7, 127.3, 126.2, 124.6,
111.2; IR ν (KBr, cm−1) 3081, 1774, 1637, 1383, 1242, 1063, 1018,
975, 761, 695; MS (ESI) m/z 294.0 (100) [M + Na]+. Anal. Calcd for
C15H10ClNO2: C, 66.31; H, 3.71; N, 5.16. Found: C, 66.01; H, 3.86;
N, 4.95.
3-(3-Bromophenyl)-4-chloro-5-phenyl-3H-oxazol-2-one (3g):
yield 84% (87.8 mg); white solid; mp 132−133 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.79 (d, J = 7.6 Hz, 2
H), 7.63−7.58 (m, 2 H), 7.46 (t, J = 7.2 Hz, 2 H), 7.43−7.35 (m, 3
H); 13C NMR δ 151.1, 134.8, 133.1, 132.3, 130.6, 130.3, 128.9, 128.8,
125.95, 125.90, 124.7, 122.7, 110.7; IR ν (KBr, cm−1) 3063, 1764,
1637, 1577, 1477, 1375, 1228, 1182, 1066, 1023, 995, 733, 676; MS
(ESI) m/z 372.0 (75) [M + Na]+. Anal. Calcd for C15H9BrClNO2: C,
51.39; H, 2.59; N, 4.00. Found: C, 51.40; H, 2.50; N, 3.87.
4-Chloro-3-(3-methoxyphenyl)-5-phenyl-3H-oxazol-2-one (3j):
yield 88% (78.1 mg); white solid; mp 94−95 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.80 (d, J = 7.6 Hz, 2
H), 7.48−7.40 (m, 3 H), 7.37 (t, J = 7.6 Hz, 1 H), 7.01 (dd, J1 = 2.0
Hz, J2 = 8.0 Hz, 2 H), 6.96 (t, J = 2.0 Hz, 1 H), 3.85 (s, 3 H); 13C
NMR δ 160.3, 151.4, 134.4, 132.8, 130.1, 128.8, 128.6, 126.2, 124.6,
119.5, 115.0, 113.0, 111.2, 55.5; IR ν (KBr, cm−1) 2956, 1763, 1634,
1498, 1473, 1380, 1251, 1218, 1041, 987, 778, 695; MS (ESI) m/z
324.1 (100) [M + Na]+. Anal. Calcd for C16H12ClNO3: C, 63.69; H,
4.01; N, 4.64. Found: C, 63.50; H, 4.25; N, 4.61.
3-(2-Bromophenyl)-4-chloro-5-phenyl-3H-oxazol-2-one (3l): yield
87% (94.2 mg); white solid; mp 108−109 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.81 (d, J = 7.2 Hz, 2
H), 7.77 (dd, J1 = 1.2 Hz, J2 = 8.0 Hz, 1 H), 7.59−7.34 (m, 6 H); 13C
NMR δ 150.7, 134.6, 133.9, 131.7, 131.2, 131.1, 128.8, 128.7, 126.2,
124.5, 124.1, 111.6; IR ν (KBr, cm−1) 3062, 1772, 1645, 1478, 1445,
1373, 1244, 1183, 1054, 1015, 974, 775, 733; MS (ESI) m/z 372.0
(78) [M + Na]+. Anal. Calcd for C15H9BrClNO2: C, 51.39; H, 2.59; N,
4.00. Found: C, 51.51; H, 2.55; N, 3.88.
3-(4-Bromophenyl)-4-chloro-5-phenyl-3H-oxazol-2-one (3n):
yield 65% (68.3 mg); white solid; mp 183−184 °C (n-hexane/ethyl
acetate); Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.78 (d, J = 7.2 Hz, 2
H), 7.66 (d, J = 6.8 Hz, 2 H), 7.46 (t, J = 7.2 Hz, 2 H), 7.41−7.35 (m,
1 H), 7.32 (d, J = 6.8 Hz, 2 H); 13C NMR δ 151.2, 134.8, 132.7, 130.9,
128.85, 128.83, 128.7, 126.0, 124.6, 123.1, 110.7; IR ν (KBr, cm−1)
3067, 1705, 1515, 1314,1224, 1062, 1008, 948, 745, 687; MS (ESI) m/
z 372.0 (76) [M + Na]+. Anal. Calcd for C15H9BrClNO2: C, 51.39; H,
2.59; N, 4.00. Found: C, 51.09; H, 2.50; N, 3.93.
3-Benzyl-4-chloro-5-phenyl-3H-oxazol-2-one (3p): yield 81%
(70.6 mg); white solid; mp 126−127 °C (n-hexane/ethyl acetate);
Rf 0.20 (vPE/vEA = 15:1); 1H NMR δ 7.70 (d, J = 7.2 Hz, 2 H), 7.48−
7.29 (m, 8 H), 4.89 (s, 2 H); 13C NMR δ 152.6, 135.1, 133.8, 128.9,
128.7, 128.4, 128.3, 127.8, 126.3, 124.3, 110.9, 45.7; IR ν (KBr, cm−1)
3062, 1757, 1642, 1491, 1439, 1382, 1341, 1184, 1056, 1018, 931, 704,
685; MS (ESI) m/z 308.1 (100) [M + Na]+. Anal. Calcd for
C16H12ClNO2: C, 67.26; H, 4.23; N, 4.90. Found: C, 67.41; H, 4.16;
N, 4.72.

Large-Scale Reaction of Ynamide 1a. The reaction of 1a (1.41g,
5.0 mmol), Pd(PPh3)4 (0.15 mmol), CuBr2 (20 mmol), K2CO3 (10
mmol), and DMF (30 mL) was carried out at 40 °C under N2
atmosphere for 1 h, and the progress of the reaction was monitored by
TLC analysis. After cooling to room temperature, the reaction mixture
</para>
3485

DOI: 10.1021/acs.joc.5b00071
J. Org. Chem. 2015, 80, 3480−3487

The Journal of Organic Chemistry

Article
<para sub=“exp”>
was quenched with ethyl acetate (30 mL) and washed with water (30
mL). The aqueous phase was extracted twice with EtOAc (3 × 20
mL), and the combined organic layer was dried over anhydrous
Na2SO4. Filtration and concentration gave the crude product, which
was puriﬁed by chromatography on silica gel (PE/EtOAc, 12:1) to
aﬀord 2a (1.31 g, 86% yield) as a white solid.
General Procedure for Suzuki−Miyaura Coupling of 4-
Bromo-oxazolones with Arylboronic Acids: Typical Procedure
III. Pd(PPh3)4 (5.0 mol %), 4-bromo-oxazolones 2 (0.3 mmol),
boronic acids (0.33 mmol), toluene (1.0 mL), ethanol (0.5 mL), and
Na2CO3 (0.6 mmol) in H2O (0.5 mL) were loaded into a 10 mL
Schlenk tube. The reaction solution was heated to 75 °C for 10 h
under nitrogen while being stirred. After completion of the reaction,
the reaction solution was neutralized by 5% aqueous HCl, and then
the aqueous phase was separated and further extracted with EtOAc (3
× 10 mL). The combined organic layers were washed with brine and
dried over Na2SO4, and then the solution was concentrated to give a
crude product, which was puriﬁed by silica gel ﬂash chromatography
on a silica gel column with petroleum ether (PE) and ethyl acetate
(EA) as eluent to aﬀord 3,4,5-multisubstituted oxazolones 4.
3,4,5-Triphenyl-3H-oxazol-2-one (4aa): yield 85% (80.1 mg);
white solid; mp 223−224 °C (n-hexane/ethyl acetate); Rf 0.20 (vPE/
vEA = 10:1); 1H NMR δ 7.41−7.20 (m, 13 H), 7.16−7.14 (m, 2 H);
13C NMR δ 153.6, 135.1, 133.6, 130.3, 129.5, 129.01, 129.00, 128.5,
128.1, 127.9, 127.6, 127.1, 126.9, 125.0, 123.5; IR ν (KBr, cm-1) 1751,
1675, 1641, 1617, 1498, 1396, 768, 619; MS (ESI) m/z 336.1 (100)
[M + Na]+. Anal. Calcd for C21H15NO2: C, 80.49; H, 4.82; N, 4.47.
Found: C, 80.37; H, 5.13; N, 4.55.
3,5-Diphenyl-4-(4-(triﬂuoromethyl)phenyl)-3H-oxazol-2-one
(4ab). yield 78% (88.1 mg); white solid; mp 156−157 °C (n-hexane/
ethyl acetate); Rf 0.20 (vPE/vEA = 12:1); 1H NMR δ 7.47 (d, J = 8.0 Hz,
2 H), 7.39−7.27 (m, 10 H), 7.15−7.10 (m, 2 H); 13C NMR δ 153.4,
136.1, 133.3, 131.3 (d), 130.8, 130.5, 129.3, 128.7, 128.3, 127.1, 126.9,
125.9 (q), 125.4, 124.9 122.2, 122.0; IR ν (KBr, cm-1) 3059, 1774,
1617,1596, 1497, 1376, 1330, 1165, 1125, 1068, 1023, 998, 769, 699;
MS (ESI) m/z 404.2 (100) [M + Na]+. Anal. Calcd for C22H14F3NO2:
C, 69.29; H, 3.70; N, 3.67. Found: C, 69.26; H, 4.07; N, 3.62.
4-(3,5-Dimethylphenyl)-3,5-diphenyl-3H-oxazol-2-one (4ac):
yield 98% (104.0 mg); white solid; mp 175−176 °C (n-hexane/
ethyl acetate); Rf 0.20 (vPE/vEA = 10:1); 1H NMR δ 7.39 (dd, J1 = 1.6
Hz, J2 = 8.4 Hz, 2 H), 7.33−7.22 (m, 6 H), 7.17−7.13 (m, 2 H), 6.98
(s, 1 H), 6.83 (s, 2 H), 2.21 (s, 6 H); 13C NMR δ 153.7, 138.6, 134.9,
133.7, 131.2, 128.9, 128.4, 127.9, 127.8, 126.9, 126.8, 124.9, 123.9,
21.1; IR ν (KBr, cm-1); MS (ESI) m/z 364.2 (100) [M + Na]+. Anal.
Calcd for C23H19NO2: C, 80.92; H, 5.61; N, 4.10. Found: C, 80.67; H,
5.91; N, 3.96.
4,5-Diphenyl-3-(3-(triﬂuoromethyl)phenyl)-3H-oxazol-2-one
(4na): yield 65% (74.1 mg); white solid; mp 140−141 °C (n-hexane/
ethyl acetate); Rf 0.20 (vPE/vEA = 10:1); 1H NMR δ 7.50 (d, J = 7.6 Hz,
1 H), 7.46−7.33 (m, 8 H), 7.30−7.25 (m, 3 H), 7.25−7.21 (m, 2 H);
13C NMR δ 153.2, 135.6, 134.2, 131.5 (q), 130.2, 130.0, 129.8, 129.6,
129.3, 128.6, 128.4, 127.3, 126.6, 125.1, 124.6, 124.4 (q), 123.6 (q),
122.9, 121.9; IR ν (KBr, cm−1) 3074, 1761, 1609, 1493, 1448, 1380,
1326, 1264, 1159, 1125, 1064, 1022, 913, 769, 694; MS (ESI) m/z
404.1 (100) [M + Na]+. Anal. Calcd for C22H14F3NO2: C, 69.29; H,
3.70; N, 3.67. Found: C, 69.51; H, 3.44; N, 3.90.

Reaction Mechanism Studies. Conditions 1. To an oven-dried
Schlenk tube purged with nitrogen and containing a magnetic stir bar
were added 1a (0.1 mmol), PdCl2(PPh3)2 (0.1 mmol), K2CO3 (0.2
mmol), and dry DMF (1.0 mL). The resulting solution was stirred at
40 °C for 20 min. After being cooled to room temperature, the
reaction mixture was quenched with ethyl acetate (15 mL) and washed
with water (30 mL). The aqueous phase was extracted twice with
EtOAc (3 × 10 mL), and the combined organic layer was dried over
anhydrous Na2SO4. Filtration, evaporation, and chromatography on
silica gel (PE/EtOAc, 15:1) aﬀorded 2a′ (58%) as a white solid.

Conditions 2. To an oven-dried Schlenk tube purged with nitrogen
and a magnetic stirrer bar were added 1a (0.3 mmol), PdCl2(PPh3)2
(0.015 mmol), CuCl2 (1.2 mmol), K2CO3 (0.6 mmol), and dry DMF
(2.0 mL), and the resulting solution was stirred at 40 °C for 20 min,

After being cooled to room temperature, the reaction mixture was
quenched with ethyl acetate (15 mL) and washed with water (30 mL).
The aqueous phase was extracted twice with EtOAc (3 × 10 mL), and
the combined organic layer was dried over anhydrous Na2SO4.
Filtration, evaporation, and chromatography on silica gel (PE/EtOAc,
20:1) aﬀorded 3a (41%) and 2a′ (18%).

Conditions 3. To an oven-dried Schlenk tube purged with nitrogen
and a magnetic stirrer bar were added 1a (0.3 mmol), Pd(PPh3)4
(0.015 mmol), CuCl (1.2 mmol), K2CO3 (0.2 mmol), and dry DMF
(2.0 mL), and the resulting solution was stirred at 40 °C for 20 min
and monitored by TLC.
Reaction of 2a′. To an oven-dried Schlenk tube purged with
nitrogen and a magnetic stirrer bar were added 2a′ (0.3 mmol),
Pd(PPh3)4 (0.015 mmol), CuCl2 (1.2 mmol), K2CO3 (0.2 mmol), and
dry DMF (2.0 mL), and the resulting solution was stirred at 40 °C for
20 min and monitored by TLC.
</para>
■ ASSOCIATED CONTENT
*S Supporting Information
1H NMR and 13C NMR spectra for all new
Copies of
compounds and X-ray crystallographic data (CIF) for
compounds 2a and 2m. This material
is available free of
charge via the Internet at http://pubs.acs.org.

■ AUTHOR INFORMATION
Corresponding Author
*E-mail: zhuhj@njtech.edu.cn.
Notes
The authors declare no competing ﬁnancial interest.

■ ACKNOWLEDGMENTS

We greatly acknowledge ﬁnancial support by the Provincal
Natural Science Foundation of
Jiangsu, China (NO.
BK20140937), and the Postgraduate Innovation Fund of
Jiangsu Province, China (2013, CXZZ13_0459; 2014,
KYLX_0774).

■ REFERENCES
(1) (a) Salerno, L.; Pittalà, V.; Modica, M. N.; Siracusa, M. A.;
Intagliata, S.; Cagnotto, A.; Salmona, M.; Kurczab, R.; Bojarski, A. J.;
Romeo, G. Eur. J. Med. Chem. 2014, 85, 716. (b) Nam, N. H.; Kim, Y.;
You, Y. J.; Hong, D. H.; Kim, H. M.; Ahn, B. Z. Bioorg. Med. Chem.
Lett. 2001, 11, 3073. (c) Kudo, N.; Taniguchi, M.; Furuta, S.; Sato, K.;
Endo, T.; Honma, T. J. Agric. Food Chem. 1998, 46, 5305. (d) Puig, C.;
Crespo, M. I.; Godessart, N.; Feixas, J.; Ibarzo, J.; Jimenez, J. M.; Soca,
L.; Cardelus, I.; Heredia, A.; Miraplex, M.; Puig, J. J. Med. Chem. 2000,
43, 214. (e) Pereira, E. R.; Sancelme, M.; Voldoire, A.; Prudhomme,
M. Bioorg. Med. Chem. Lett. 1997, 7, 2503. (f) Fearnley, S. P.;
Thongsornkleeb, C. J. Org. Chem. 2010, 75, 933. (g) Nomura, I.;
Mukai, C. Org. Lett. 2002, 4, 4301. (h) Hashimoto, N.; Ishizuka, T.;
Kunieda, T. Tetrahedron Lett. 1994, 35, 721.
(2) For selected examples, see: (a) Yamashita, M.; Lee, S. H.; Koch,
G.; Zimmermann, J.; Clapham, B.; Janda, K. D. Tetrahedron Lett. 2005,
46, 5495. (b) Jiang, H. F.; Zhao, J. W.; Wang, A. Z. Synthesis 2008, 5,
763. (c) Hamad, M. O.; Kiptoo, P. K.; Stinchcomb, A. L.; Crooks, P.
A. Biorg. Med. Chem. 2006, 14, 7051. (d) Marques, C. A.; Selva, M.;
Tundo, P.; Montanari, F. J. Org. Chem. 1993, 58, 5765. (e) Aichaoui,
H.; Poupaert, J. H.; Lesieur, D.; Henichart, J. P. Tetrahedron 1991, 47,
6649. (f) Ram, R. N.; Soni, V. K. J. Org. Chem. 2013, 78, 11935.
(3) (a) Istrate, F. M.; Buzas, A. K.; Jurberg, I. D.; Odabachian, Y.;
Gagosz, F. Org. Lett. 2008, 10, 925. (b) Hashmi, A. S. K.; Salathé, R.;
Frey, W. Synlett 2007, 11, 1763. (c) Lu, Z.; Yang, Z.; Cui, W.; Zhu, G.
Chem. Lett. 2012, 41, 636. (d) Lu, Z.; Cui, W.; Xia, S.; Bai, Y.; Luo, F.;
Zhu, G. J. Org. Chem. 2012, 77, 9871. (e) Lu, Z.; Xu, X.; Yang, Z.;
Kong, L.; Zhu, G. Tetrahedron Lett. 2012, 53, 3433.

3486

DOI: 10.1021/acs.joc.5b00071
J. Org. Chem. 2015, 80, 3480−3487

Article

The Journal of Organic Chemistry

(4) (a) Lu, Z.; Luo, F.; Wang, L.; Zhu, G. J. Org. Chem. 2013, 78,
10894. (b) Hu, J.; Ma, J.; Zhang, Z.; Zhu, Q.; Zhou, H.; Lu, W.; Han,
B. Green Chem. 2015, 17, 1219.
(5) (a) Zhang, H. P.; Yu, S. C.; Liang, Y.; Peng, P.; Tang, B. X.; Li, J.
H. Synlett 2011, 982. (b) Beccalli, E. M.; Broggini, G.; Gazzola, S.;
Mazza, A. Org. Biomol. Chem. 2014, 12, 6767. (c) Huang, L.; Wang,
Q.; Liu, X.; Jiang, H. Angew. Chem., Int. Ed. 2012, 51, 5696. (d) Li, Y.;
Jardine, K. J.; Tan, R.; Song, D.; Dong, V. M. Angew. Chem., Int. Ed.
2009, 48, 9690. (e) Ye, S.; Gao, K.; Zhou, H.; Yang, X.; Wu, J. Chem.
Commun. 2009, 5406.
(6) (a) Borsini, E.; Broggini, G.; Fasana, A.; Galli, S.; Khansaa, M.;
Piarulli, U.; Rigamonti, M. Adv. Synth. Catal. 2011, 353, 985. (b) Xiao,
Y.; Zhang, J. Chem. Commun. 2009, 3594. (c) Muniz, K.; Iglesias, A.;
Fang, Y. Chem. Commun. 2009, 5591.
(7) (a) He, G.; Zhang, Q.; Huang, H.; Chen, S.; Wang, Q.; Zhang,
D.; Zhang, R.; Zhu, H. Eur. J. Org. Chem. 2013, 6979. (b) He, G.;
Chen, S.; Wang, Q.; Huang, H.; Zhang, Q.; Zhang, D.; Zhang, R.; Zhu,
H. Org. Biomol. Chem. 2014, 12, 5945. (c) Huang, H.; He, G.; Zhu, X.;
Jin, X.; Qiu, S.; Zhu, H. Eur. J. Org. Chem. 2014, 7174.
(8) (a) Ma, D.; Cai, Q. Acc. Chem. Res. 2008, 41, 1450. (b) Rossi, R.;
Bellina, F.; Lessi, M. Tetrahedron 2011, 67, 6969. (c) Chinchilla, R.;
Najera, C. Chem. Soc. Rev. 2011, 40, 5084.
(9) (a) Chang, W.; Lo, Y. H.; Lee, C. Y.; Wu, M. J. Adv. Synth. Catal.
2008, 350, 1248. (b) Liang, Y.; Tang, S.; Zhang, X.; Mao, L.; Xie, Y.;
Li, J. Org. Lett. 2006, 8, 3017.
(10) (a) Monleón, A.; Blay, G.; Domingo, L. R.; Muñoz, M. C.;
Pedro, J. R. Chem.Eur. J. 2013, 19, 14852. (b) Monleón, A.; Blay, G.;
Domingo, L. R.; Muñoz, M. C.; Pedro, J. R. Eur. J. Org. Chem. 2015,
1020. (c) Michael, F. E.; Sibbald, P. A.; Cochran, B. M. Org. Lett. 2008,
10, 793.
(11) (a) Ji, J.; Zhang, C.; Lu, X. J. Org. Chem. 1995, 60, 1160.
(b) Huang, X.; Wang, F.; Liang, Y.; Li, J. Org. Lett. 2009, 11, 1139.
(c) Tang, S.; Yu, Q.; Peng, P.; Li, J.; Zhong, P.; Tang, R. Org. Lett.
2007, 9, 3413. (d) Ma, S.; Wu, B.; Zhao, S. Org. Lett. 2003, 5, 4429.
(12) (a) DeKorver, K. A.; Li, H.; Lohse, A. G.; Hayashi, R.; Lu, Z.;
Zhang, Y.; Hsung, R. P. Chem. Rev. 2010, 110, 5064. (b) Evano, G.;
Coste, A.; Jouvin, K. Angew. Chem., Int. Ed. 2010, 49, 2840. (c) Wang,
X. N.; Yeom, H. S.; Fang, L. C.; He, S.; Ma, Z. X.; Kedrowski, B. L.;
Hsung, R. P. Acc. Chem. Res. 2014, 47, 560.
(13) Liang, Y.; Tang, S.; Zhang, X.; Mao, Li.; Xie, Ye.; Li, J. Org. Lett.
2006, 8, 3017.
(14) Chai, D. I.; Hoffmeister, L.; Lautens, M. Org. Lett. 2011, 13, 106.
(15) (a) Yoshida, M.; Higuchi, M.; Shishido, K. Tetrahedron 2010,
66, 2675. (b) Hövelmann, C. H.; Streuff, J.; Brelot, L.; Muñiz, K.
Chem. Commun. 2008, 2334.
(16) Hofmeister, H.; Annen, K.; Laurent, H.; Wiechert, R. Angew.
Chem., Int. Ed. Engl. 1984, 23, 727; Angew. Chem. 1984, 96, 720.
(17) Xue, J.; Luo, M.; Wen, Y.; Ye, M.; Liu, L.; Chen, Z. Synthesis
2014, 46, 3191.

3487

DOI: 10.1021/acs.joc.5b00071
J. Org. Chem. 2015, 80, 3480−3487

